The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial
Open accessAbstract
Purpose: Neurotoxic effects of brain irradiation include cognitive impairment in 50% to 90% of patients. Prior studies have suggested that donepezil, a neurotransmitter modulator, may improve cognitive function. Patients and Methods: A total of 198 adult brain tumor survivors ≥ 6 months after partial- or whole-brain irradiation were randomly assigned to receive a single daily dose (5 mg for 6 weeks, 10 mg for 18 weeks) of donepezil or placebo. A cognitive test battery assessing memory, attention, language, visuomotor, verbal fluency, and executive functions was administered before random assignment and at 12 and 24 weeks. A cognitive composite score (primary outcome) and individual cognitive domains were evaluated. Results: Of this mostly middle-age, married, non-Hispanic white sample, 66% had primary brain tumors, 27% had brain metastases, and 8% underwent prophylactic cranial irradiation. After 24 weeks of treatment, the composite scores did not differ significantly between groups (P = .48); however, significant differences favoring donepezil were observed for memory (recognition, P = .027; discrimination, P = .007) and motor speed and dexterity (P = .016). Significant interactions between pretreatment cognitive function and treatment were found for cognitive composite (P = .01), immediate recall (P = .05), delayed recall (P = .004), attention (P = .01), visuomotor skills (P = .02), and motor speed and dexterity (P < .001), with the benefits of donepezil greater for those who were more cognitively impaired before study treatment. Conclusion: Treatment with donepezil did not significantly improve the overall composite score, but it did result in modest improvements in several cognitive functions, especially among patients with greater pretreatment impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Cancer treatment and survivorship statistics, 2014
DeSantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., Alteri, R., Robbins, A. S., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21235 · Cited by 2,779
Group sequential methods in the design and analysis of clinical trials
POCOCK, S. J. (1977) · Biometrika · doi:10.1093/biomet/64.2.191 · Cited by 1,831
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
The hopkins verbal learning test: Development of a new memory test with six equivalent forms
Brandt, J. (1991) · Clinical Neuropsychologist · doi:10.1080/13854049108403297 · Cited by 1,317 · cited 1×
“Measures Verbal learning and memory were assessed with the Hopkins Verbal Learning Test–Revised (HVLT-R).(20) HVLT-R variables included learning (total recall, sum of three learning trials; score range, 0 to 36), memory (delayed recall [DR], trial four; score range, 0 to 12), percent savings ([DR highest of last two l…”
MethodDonepezil for dementia due to Alzheimer’s disease.
Birks, J. S., & Harvey, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub3 · Cited by 1,200
Brown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., Choucair, A., Fox, S., Suh, J. H., Roberge, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not114 · Cited by 958
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
Treatment of Alzheimer's disease; current status and new perspectives
scarpini, E., Schelterns, P., & Feldman, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00502-7 · Cited by 721
Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Benton controlled oral word association test: Reliability and updated norms
Ruff, R. (1996) · Archives of Clinical Neuropsychology · doi:10.1016/0887-6177(95)00033-x · Cited by 617
Meyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585
Madsen, T. M., Kristjansen, P. E. G., Bolwig, T. G., & Wörtwein, G. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00199-4 · Cited by 497
Shaw, E. G., Rosdhal, R., D'Agostino, R. B., Lovato, J., Naughton, M. J., Robbins, M. E., & Rapp, S. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3001 · Cited by 326
Self-citationDonepezil improved memory in multiple sclerosis in a randomized clinical trial
Krupp, L. B., Christodoulou, C., Melville, P., Scherl, W. F., MacAllister, W. S., & Elkins, L. E. (2004) · Neurology · doi:10.1212/01.wnl.0000142989.09633.5a · Cited by 300
[Wechsler Adult Intelligence Scale-III (WAIS-III)].
Yamamoto, D., Kazui, H., & Takeda, M. (2011) · PubMed · Cited by 300
Donepezil for dementia due to Alzheimer's disease
Birks, J., & Harvey, R. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub2 · Cited by 285
Cancer therapy-associated CNS neuropathology: an update and review of the literature
Perry, A., & Schmidt, R. E. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0023-y · Cited by 233
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
Leroi, I., Brandt, J., Reich, S. G., Lyketsos, C. G., Grill, S., Thompson, R., & Marsh, L. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.993 · Cited by 226
Zhang, L., Plotkin, R. C., Wang, G., Sandel, M. E., & Lee, S. (2004) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2003.10.014 · Cited by 177
The handbook of Rey-Osterrieth Complex Figure Usage : clinical and research applications
Knight, J., & Kaplan, E. (2003) · Medical Entomology and Zoology · Cited by 108
Cholinergic enhancement of episodic memory in healthy young adults
Grön, G., Kirstein, M., Thielscher, A., Riepe, M. W., & Spitzer, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0043-2 · Cited by 100
Cerebral Perfusional Effects of Cholinesterase Inhibitors in Alzheimer Disease
Ceravolo, R., Volterrani, D., Tognoni, G., Dell’Agnello, G., Manca, G., Kiferle, L., Rossi, C. A., Logi, C., Strausś, H. W., Mariani, G., et al. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000138636.42121.45 · Cited by 54
Pinkham, M. B., Bertrand, K. C., Olson, S., Zarate, D., Oram, J., Pullar, A. P., & Foote, M. C. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.04.005 · Cited by 33
Implementation of Pattern-Mixture Models Using Standard SAS/STAT Procedures
Ratitch, B. (2011) · Cited by 26
Salloway, S., Mintzer, J. E., Cummings, J. L., Geldmacher, D., Sun, Y., Yardley, J., & Mackell, J. A. (2012) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512454708 · Cited by 25
Cited by
Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.9839 · Cited by 1,671
Self-citationWen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Brown, P. D., Gondi, V., Pugh, S., Tome, W. A., Wefel, J. S., Armstrong, T. S., Bovi, J. A., Robinson, C., Konski, A., Khuntia, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02767 · Cited by 846
Current approaches to the management of brain metastases
Suh, J. H., Kotecha, R., Chao, S. T., Ahluwalia, M. S., Sahgal, A., & Chang, E. L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0320-3 · Cited by 553
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Wang, K., & Tepper, J. E. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21689 · Cited by 449
Metadata
- Authors
- Rapp, S. R., Case, L. D., Peiffer, A., Naughton, M. M., Chan, M. D., Stieber, V. W., Moore, D. F., Falchuk, S. C., Piephoff, J. V., Edenfield, W. J., Giguere, J. K., Loghin, M. E., & Shaw, E. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-05-20
- Volume
- 33
- Issue
- 15
- Pages
- 1653-1659
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2154563173
- Cited by
- 270
- References
- 28
- FWCI
- 21.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.